Targeting autophagy to enhance oncolytic virus-based cancer therapy

Bibliography

• Cattaneo R, Miest T, Shashkova EV, et al. Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded. Nat Rev Microbiol 2008;6(7):529-40
   PubMed Web of Science ®Google Scholar
• Prestwich RJ, Ilett EJ, Errington F, et al. Immune-mediated antitumor activity of reovirus is required for therapy and is independent of direct viral oncolysis and replication. Clin Cancer Res 2009;15(13):4374-81
   PubMed Web of Science ®Google Scholar
• Tysome JR, Lemoine NR, Wang Y. Combination of anti-angiogenic therapy and virotherapy: arming oncolytic viruses with anti-angiogenic genes. Curr Opin Mol Ther 2009;11(6):664-9
   PubMed Web of Science ®Google Scholar
• Kroemer G, Marino G, Levine B. Autophagy and the integrated stress response. Mol Cell 2010;40(2):280-93
   PubMed Web of Science ®Google Scholar
• Chen Y, Klionsky DJ. The regulation of autophagy - unanswered questions. J Cell Sci 2011;124(Pt 2):161-70
   PubMed Web of Science ®Google Scholar
• Kraft C, Martens S. Mechanisms and regulation of autophagosome formation. Curr Opin Cell Biol 2012;24(4):496-501
   PubMed Web of Science ®Google Scholar
• Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol 2010;221(1):3-12
   PubMed Web of Science ®Google Scholar
• Kimmelman AC. The dynamic nature of autophagy in cancer. Genes Dev 2011;25(19):1999-2010
   PubMed Web of Science ®Google Scholar
• Mathew R, White E. Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night. Curr Opin Genet Dev 2011;21(1):113-19
   PubMed Web of Science ®Google Scholar
• Liang XH, Jackson S, Seaman M, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999;402(6762):672-6
   PubMed Web of Science ®Google Scholar
• Chen HY, White E. Role of autophagy in cancer prevention. Cancer Prev Res (Phila) 2011;4(7):973-83
   PubMed Web of Science ®Google Scholar
• Chen N, Karantza V. Autophagy as a therapeutic target in cancer. Cancer Biol Ther 2011;11(2):157-68
   PubMed Web of Science ®Google Scholar
• Amaravadi RK, Lippincott-Schwartz J, Yin XM, et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 2011;17(4):654-66
   PubMed Web of Science ®Google Scholar
• Levy JM, Thorburn A. Targeting autophagy during cancer therapy to improve clinical outcomes. Pharmacol Ther 2011;131(1):130-41
   PubMed Web of Science ®Google Scholar
• Deretic V, Levine B. Autophagy, immunity, and microbial adaptations. Cell Host Microbe 2009;5(6):527-49
   PubMed Web of Science ®Google Scholar
• Kuballa P, Nolte WM, Castoreno AB, et al. Autophagy and the immune system. Annu Rev Immunol 2012;30:611-46
   PubMed Web of Science ®Google Scholar
• Kudchodkar SB, Levine B. Viruses and autophagy. Rev Med Virol 2009;19(6):359-78
   PubMed Web of Science ®Google Scholar
• Sumpter R Jr, Levine B. Selective autophagy and viruses. Autophagy 2011;7(3):260-5
   PubMed Web of Science ®Google Scholar
• Dreux M, Chisari FV. Viruses and the autophagy machinery. Cell Cycle 2010;9(7):1295-307
   PubMed Web of Science ®Google Scholar
• Liang XH, Kleeman LK, Jiang HH, et al. Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol 1998;72(11):8586-96
   PubMed Web of Science ®Google Scholar
• Nakashima A, Tanaka N, Tamai K, et al. Survival of parvovirus B19-infected cells by cellular autophagy. Virology 2006;349(2):254-63
   PubMed Web of Science ®Google Scholar
• Orvedahl A, MacPherson S, Sumpter R Jr, et al. Autophagy protects against sindbis virus infection of the central nervous system. Cell Host Microbe 2010;7(2):115-27
   PubMed Web of Science ®Google Scholar
• McFarlane S, Aitken J, Sutherland JS, et al. Early induction of autophagy in human fibroblasts after infection with human cytomegalovirus or herpes simplex virus 1. J Virol 2011;85(9):4212-21
   PubMed Web of Science ®Google Scholar
• English L, Chemali M, Duron J, et al. Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection. Nat Immunol 2009;10(5):480-7
   PubMed Web of Science ®Google Scholar
• Prentice E, Jerome WG, Yoshimori T, et al. Coronavirus replication complex formation utilizes components of cellular autophagy. J Biol Chem 2004;279(11):10136-41
   PubMed Web of Science ®Google Scholar
• Belov GA, Habbersett C, Franco D, et al. Activation of cellular Arf GTPases by poliovirus protein 3CD correlates with virus replication. J Virol 2007;81(17):9259-67
   PubMed Web of Science ®Google Scholar
• Wong J, Zhang J, Si X, et al. Autophagosome supports coxsackievirus B3 replication in host cells. J Virol 2008;82(18):9143-53
   PubMed Web of Science ®Google Scholar
• Yoon SY, Ha YE, Choi JE, et al. Autophagy in coxsackievirus-infected neurons. Autophagy 2009;5(3):388-9
   PubMed Web of Science ®Google Scholar
• Alonso MM, Jiang H, Yokoyama T, et al. Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death. Mol Ther 2008;16(3):487-93
   PubMed Web of Science ®Google Scholar
• Rodriguez-Rocha H, Gomez-Gutierrez JG, Garcia-Garcia A, et al. Adenoviruses induce autophagy to promote virus replication and oncolysis. Virology 2011;416(1-2):9-15
   PubMed Web of Science ®Google Scholar
• Jiang H, White EJ, Rios-Vicil CI, et al. Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity. J Virol 2011;85(10):4720-9
   PubMed Web of Science ®Google Scholar
• Zhang H, Monken CE, Zhang Y, et al. Cellular autophagy machinery is not required for vaccinia virus replication and maturation. Autophagy 2006;2(2):91-5
   PubMed Web of Science ®Google Scholar
• Moloughney JG, Monken CE, Tao H, et al. Vaccinia virus leads to ATG12-ATG3 conjugation and deficiency in autophagosome formation. Autophagy 2011;7(12):1434-47
   PubMed Web of Science ®Google Scholar
• Ito H, Aoki H, Kuhnel F, et al. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus. J Natl Cancer Inst 2006;98(9):625-36
   PubMed Web of Science ®Google Scholar
• Baird SK, Aerts JL, Eddaoudi A, et al. Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer. Oncogene 2008;27(22):3081-90
   PubMed Web of Science ®Google Scholar
• Botta G, Passaro C, Libertini S, et al. Inhibition of autophagy enhances the effects of E1A-defective oncolytic adenovirus dl922-947 against glioma cells in vitro and in vivo. Hum Gene Ther 2012;23(6):623-34
   PubMed Web of Science ®Google Scholar
• Jiang H, Gomez-Manzano C, Aoki H, et al. Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death. J Natl Cancer Inst 2007;99(18):1410-14
   PubMed Web of Science ®Google Scholar
• Rajecki M, af Hallstrom T, Hakkarainen T, et al. Mre11 inhibition by oncolytic adenovirus associates with autophagy and underlies synergy with ionizing radiation. Int J Cancer 2009;125(10):2441-9
   PubMed Web of Science ®Google Scholar
• Schache P, Gurlevik E, Struver N, et al. VSV virotherapy improves chemotherapy by triggering apoptosis due to proteasomal degradation of Mcl-1. Gene Ther 2009;16(7):849-61
   PubMed Web of Science ®Google Scholar
• Meng S, Jiang K, Zhang X, et al. Avian reovirus triggers autophagy in primary chicken fibroblast cells and vero cells to promote virus production. Arch Virol 2012;157(4):661-8
   PubMed Web of Science ®Google Scholar
• Meng C, Zhou Z, Jiang K, et al. Newcastle disease virus triggers autophagy in U251 glioma cells to enhance virus replication. Arch Virol 2012;157(6):1011-18
   PubMed Web of Science ®Google Scholar
• Tazawa H, Yano S, Yoshida R, et al. Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axis. Int J Cancer 2012;131(12):2939-50
   PubMed Web of Science ®Google Scholar
• Joubert PE, Meiffren G, Gregoire IP, et al. Autophagy induction by the pathogen receptor CD46. Cell Host Microbe 2009;6(4):354-66
   PubMed Web of Science ®Google Scholar
• Gregoire IP, Richetta C, Meyniel-Schicklin L, et al. IRGM is a common target of RNA viruses that subvert the autophagy network. PLoS Pathog 2011;7(12):e1002422
   PubMed Web of Science ®Google Scholar
• Gregoire IP, Rabourdin-Combe C, Faure M. Autophagy and RNA virus interactomes reveal IRGM as a common target. Autophagy 2012;8(7):1136-7
   PubMed Web of Science ®Google Scholar
• Ulasov IV, Tyler MA, Zhu ZB, et al. Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy. Int J Oncol 2009;34(3):729-42
   PubMed Web of Science ®Google Scholar
• Yokoyama T, Iwado E, Kondo Y, et al. Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells. Gene Ther 2008;15(17):1233-9
   PubMed Web of Science ®Google Scholar
• Yu L, Baxter PA, Voicu H, et al. A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo. Neurol Oncol 2010;12(6):580-94
   PubMed Web of Science ®Google Scholar
• Colunga AG, Laing JM, Aurelian L. The HSV-2 mutant DeltaPK induces melanoma oncolysis through nonredundant death programs and associated with autophagy and pyroptosis proteins. Gene Ther 2010;17(3):315-27
   PubMed Web of Science ®Google Scholar
• Kanai R, Zaupa C, Sgubin D, et al. Effect of gamma34.5 deletions on oncolytic herpes simplex virus activity in brain tumors. J Virol 2012;86(8):4420-31
   PubMed Web of Science ®Google Scholar
• Ottolino-Perry K, Diallo JS, Lichty BD, et al. Intelligent design: combination therapy with oncolytic viruses. Mol Ther 2010;18(2):251-63
   PubMed Web of Science ®Google Scholar
• Eager RM, Nemunaitis J. Clinical development directions in oncolytic viral therapy. Cancer Gene Ther 2011;18(5):305-17
   PubMed Web of Science ®Google Scholar
• Nguyen TL, Wilson MG, Hiscott J. Oncolytic viruses and histone deacetylase inhibitors–a multi-pronged strategy to target tumor cells. Cytokine Growth Factor Rev 2010;21(2-3):153-9
   PubMed Web of Science ®Google Scholar
• Kumar S, Gao L, Yeagy B, et al. Virus combinations and chemotherapy for the treatment of human cancers. Curr Opin Mol Ther 2008;10(4):371-9
   PubMed Web of Science ®Google Scholar
• Yang ZJ, Chee CE, Huang S, et al. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther 2011;10(9):1533-41
   PubMed Web of Science ®Google Scholar
• Dalby KN, Tekedereli I, Lopez-Berestein G, et al. Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy 2010;6(3):322-9
   PubMed Web of Science ®Google Scholar
• Amaravadi RK. Cancer. Autophagy in tumor immunity. Science 2011;334(6062):1501-2
   PubMed Web of Science ®Google Scholar
• Homicsko K, Lukashev A, Iggo RD. RAD001 (everolimus) improves the efficacy of replicating adenoviruses that target colon cancer. Cancer Res 2005;65(15):6882-90
   PubMed Web of Science ®Google Scholar
• Lukashev AN, Fuerer C, Chen MJ, et al. Late expression of nitroreductase in an oncolytic adenovirus sensitizes colon cancer cells to the prodrug CB1954. Hum Gene Ther 2005;16(12):1473-83
   PubMed Web of Science ®Google Scholar
• Lun XQ, Zhou H, Alain T, et al. Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin. Cancer Res 2007;67(18):8818-27
   PubMed Web of Science ®Google Scholar
• Stanford MM, Shaban M, Barrett JW, et al. Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo. Mol Ther 2008;16(1):52-9
   PubMed Web of Science ®Google Scholar
• Lun X, Alain T, Zemp FJ, et al. Myxoma virus virotherapy for glioma in immunocompetent animal models: optimizing administration routes and synergy with rapamycin. Cancer Res 2010;70(2):598-608
   PubMed Web of Science ®Google Scholar
• Lun XQ, Jang JH, Tang N, et al. Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide. Clin Cancer Res 2009;15(8):2777-88
   PubMed Web of Science ®Google Scholar
• Alain T, Lun X, Martineau Y, et al. Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production. Proc Natl Acad Sci USA 2010;107(4):1576-81
   PubMed Web of Science ®Google Scholar
• Fu X, Tao L, Rivera A, et al. Rapamycin enhances the activity of oncolytic herpes simplex virus against tumor cells that are resistant to virus replication. Int J Cancer 2011;129(6):1503-10
   PubMed Web of Science ®Google Scholar
• McAfee Q, Zhang Z, Samanta A, et al. Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency. Proc Natl Acad Sci USA 2012;109(21):8253-8
   PubMed Web of Science ®Google Scholar
• Amaravadi RK, Winkler JD. Lys05: a new lysosomal autophagy inhibitor. Autophagy 2012;8(9):1383-4
   PubMed Web of Science ®Google Scholar
• Carew JS, Espitia CM, Esquivel JA II, et al. Lucanthone is a novel inhibitor of autophagy that induces cathepsin D-mediated apoptosis. J Biol Chem 2011;286(8):6602-13
   PubMed Web of Science ®Google Scholar
• Alkassar M, Gartner B, Roemer K, et al. The combined effects of oncolytic reovirus plus Newcastle disease virus and reovirus plus parvovirus on U87 and U373 cells in vitro and in vivo. J Neurooncol 2011;104(3):715-27
   PubMed Web of Science ®Google Scholar
• Ertmer A, Huber V, Gilch S, et al. The anticancer drug imatinib induces cellular autophagy. Leukemia 2007;21(5):936-42
   PubMed Web of Science ®Google Scholar
• Li X, Fan Z. The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1/hVps34 complex. Cancer Res 2010;70(14):5942-52
   PubMed Web of Science ®Google Scholar
• Maycotte P, Thorburn A. Autophagy and cancer therapy. Cancer Biol Ther 2011;11(2):127-37
   PubMed Web of Science ®Google Scholar
• Fu J, Shao CJ, Chen FR, et al. Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines. Neurol Oncol 2010;12(4):328-40
   PubMed Web of Science ®Google Scholar
• Cloonan SM, Williams DC. The antidepressants maprotiline and fluoxetine induce Type II autophagic cell death in drug-resistant Burkitt's lymphoma. Int J Cancer 2011;128(7):1712-23
   PubMed Web of Science ®Google Scholar
• Cloonan SM, Drozgowska A, Fayne D, et al. The antidepressants maprotiline and fluoxetine have potent selective antiproliferative effects against Burkitt lymphoma independently of the norepinephrine and serotonin transporters. Leuk Lymphoma 2010;51(3):523-39
   PubMed Web of Science ®Google Scholar
• Bursch W, Ellinger A, Kienzl H, et al. Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis 1996;17(8):1595-607
   PubMed Web of Science ®Google Scholar
• Carew JS, Giles FJ, Nawrocki ST. Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy. Cancer Lett 2008;269(1):7-17
   PubMed Web of Science ®Google Scholar
• Gammoh N, Lam D, Puente C, et al. Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death. Proc Natl Acad Sci USA 2012;109(17):6561-5
   PubMed Web of Science ®Google Scholar
• Yang ZJ, Chee CE, Huang S, et al. Autophagy modulation for cancer therapy. Cancer Biol Ther 2011;11(2):169-76
   PubMed Web of Science ®Google Scholar
• Shacka JJ, Klocke BJ, Roth KA. Autophagy, bafilomycin and cell death: the "a-B-cs" of plecomacrolide-induced neuroprotection. Autophagy 2006;2(3):228-30
   PubMed Web of Science ®Google Scholar